Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–7 of 7 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT03011814
- Conditions
- Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT03017820
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Not Yet Recruiting
Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma
NCT07691450
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +36 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT04074746
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01590732
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
NCT03598998
- Conditions
- Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
Active, Not Recruiting
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin
NCT03278782
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States